|
Click here to sign the guestbook
|
|
1
|
http://goldgirlxxx.xyz/
219.237.78.2
|
|
|
|
|
2
|
http://goldgirlxxx.xyz/
14.241.233.173
|
|
|
|
|
3
|
http://goldgirlxxx.xyz/
185.213.110.65
|
|
|
|
|
4
|
http://goldgirlxxx.xyz/
220.180.107.235
|
|
|
|
|
5
|
http://goldgirlxxx.xyz/
221.215.87.163
|
|
|
|
|
6
|
http://goldgirlxxx.xyz/
63.143.98.57
|
|
|
|
|
7
|
November 19, 2025 - 03:36 AM
power washing company near me
|
  |
| |
Surprisingly user friendly website. Great details readily available on few clicks on.
|
|
|
|
8
|
November 19, 2025 - 03:33 AM
HighStakesDB - High Stakes Poker, News, Deals
|
|
| |
Incredibly user friendly website. Great info available on couple of gos to.
|
|
|
|
9
|
November 19, 2025 - 03:19 AM
DennisereRophy
|
|
| |
Wbfs U.S. Judge s Ruling Keeps Open Last Abortion Clinic In Kentucky
A Record That Keeps Getting Broken: Hemophilia Treatment Poised To Become Most Expensive Drug In WorldThe gene therapy, which isn 03 <a href=https://www.bru-mate.ca>brumate canada</a> 9;t officially priced yet, was extremely successful in trials. Its maker says that insurers seem on board with paying somewhere between $2 million and $3 million for the drug, which would break the previous record held by Novartis spinal muscular atrophy drug. Experts warned when Novartis drug was approved at its $2.1 million price that it was setting a bad precedent. In other pharmaceutical news: more updates from the JP Morgan conference, the science behind the Ebola vaccine, a diabetes pill, and more.The Wall Street Journal:BioMarin Explores Pricing Experimental Gen <a href=https://www.stanleycups.com.de>stanley cup becher</a> e Therapy At $2 Million To $3 MillionBioMarin Pharmaceutical Inc. BMRN 0.29% is exploring pricing its experimental gene therapy for hemophilia patients between $2 million and $3 million if it is approved, which could make it the most expensive drug in the world. The company hasnt yet announced a price for the therapy, but Chief Executive Jean-Jacques Bienaim茅 said in an interview at the J.P. Morgan Healthcare Conference that the drugmaker has spoken to insurers, who have indicated they are comfortable with the range. Hopkins, 1/16 Reuters:Eli Lilly Targets Quarterly Deals Of $1 Billion-$5 Billion In 2020: CFOEli Lilly and Co aims to announce roughly one $1 billion to $5 billion dea <a href=https://www.hydro-flasks.us>hydro flask usa</a> l every quarter in 2020, its chief financial officer told Reuters, as the U.S. drugmaker Muok AP: Poll Shows Support For Health Law Drops With Budget Woes
Minorities More Likely Than Whites To Seek Aggressive End-of-Life Care, Studies FindThe Washington Post on Monday examined how blacks and other minorities are more likely than whites to want, an...
|
|
|
|
10
|
November 19, 2025 - 03:13 AM
Rafa77
|
|
| |
I like this post, enjoyed this one thank you for posting.
|
|
|
| [Top] Page # 1 2 3 4 5 6 7 8 9 10 ... of 30 [Bottom] |